Articles tagged with Inhibitory Effects
A team led by Michael Kyba identified an inhibitor that protects cells from toxic effects associated with facioscapulohumeral muscular dystrophy (FSHD) in cells and mice. The compound, iP300w, blocks the p300 enzyme needed by the DUX4 protein, preventing its toxic effects.
A new review of scientific literature suggests that medium doses of ADHD medication have the strongest beneficial effects on inhibitory control, a key aspect of impulsiveness. Increasing doses beyond this point may not make a significant difference in symptoms.
Researchers at Max Planck Florida Institute for Neuroscience developed a strategy to label and map local inhibitory inputs onto cells. They found that inhibitory inputs may parallel or diverge from target neurons, revealing a diverse palette of inhibition. This discovery suggests complex functional connectivity in the visual cortex.
Researchers found that using high UVA protection factor sunscreen allows for better vitamin D synthesis due to increased UVB transmission. Despite concerns, optimal sunscreen use does not harm vitamin D production, according to a new study published in the British Journal of Dermatology.
Median nerve stimulation triggers release of neuropeptide orexin from hypothalamus, leading to reduced inhibitory control in midbrain's pain-control region. This analgesic effect depends on endocannabinoid receptors, not opioid receptors.
Researchers find that glucitol-core-containing gallotannins from red maple leaves can block elastase activity, maintaining skin elasticity. The findings could lead to the development of plant-based skincare products and create new economic opportunities for farmers in eastern North America.
A study published in Journal of Clinical Investigation found that adult-onset progressive degenerative diseases have their roots in early developmental defects. Researchers used a mouse model of spinocerebellar ataxia type 1 and discovered altered neural circuitry in the cerebellum, which sets the stage for later disease vulnerability.
Researchers at Aarhus University have developed a llama-antibody, or nanobody, that can prevent the cleavage of the C3 protein, which plays a crucial role in the innate immune system. This breakthrough could lead to new treatments for kidney diseases and conditions where the immune system is overactive.
A single-center study found that cancer immunotherapy is safe for patients with rheumatologic diseases, with only a minority experiencing adverse effects. The treatment was successfully administered to all six affected patients, paving the way for its use in select groups with pre-existing conditions.
Researchers developed a neutralizing agent for CSPGs that inhibit oligodendrocyte migration and differentiation. Protamine was found to inhibit CSPG-mediated inhibition of oligodendrocyte differentiation, enhancing myelination in the developing mouse brain and remyelination in adult mice.
Researchers discovered a novel form of crosstalk among tumor cells and immune cells that inhibits the effectiveness of immunotherapeutic strategies. Combining CSF-1R inhibitors with selective CXCR2 inhibitors shows significant anti-tumor effects, suggesting new approaches to enhance therapeutic efficacy.
A University of Oregon study found that bilingual preschoolers develop faster inhibitory control skills than monolingual peers. The research used a longitudinal approach to examine the effects of bilingualism on executive function development in low-income children.
Researchers have discovered a class of compounds that selectively inhibit fibrosis-initiating TGF-β pathways in fibroblasts, without affecting non-fibrogenic cells. These trihydroxyphenolic compounds may provide an opportunity to treat fibrosis with fewer side effects.
A recent study found that the clinical benefit of LDL cholesterol lowering therapies depends on how it is lowered, with apoB particles playing a key role. The study used genetically randomized participants and found that reducing apoB levels had a greater impact on cardiovascular risk than reducing LDL cholesterol.
Researchers discovered that combining palbociclib with autophagy inhibitors can significantly reduce side effects and improve treatment efficacy for ER+ breast cancer patients. The study found that Rb and cytoplasmic cyclin E biomarkers predict response to therapy, allowing for personalized treatment approaches.
SGLT2 inhibitors demonstrate renoprotective effects by reducing intraglomerular pressure, hyperfiltration, and improving renal function in patients with diabetes. Additionally, these drugs modulate the renin-angiotensin axis, which may contribute to their observed benefits.
Researchers at Whitehead Institute for Biomedical Research used precise genetic tools to track neurophysiological deficits resulting from Rett Syndrome. They found that recombinant human Insulin Like Growth Factor 1 (rhIGF1) and bumetanide can reverse such deficits in a cell-type specific manner.
A DNA-modulating drug, BET inhibitor, attenuates CF lung inflammation by suppressing Th17 cell response and inflammatory factor release. In a mouse model, BET inhibitor treatment decreases lung inflammation without promoting infection, suggesting potential therapeutic use for CF patients.
Researchers have discovered a new approach to modulating synapses using graphene flakes, which buffer activity without acting on the brain or neurosurgery. The method is selective for excitatory synapses and could be used to target certain diseases with non-invasive treatments.
A study published in Psychopharmacology found that the smell of alcohol can reduce a person's ability to inhibit their behavior, particularly when it comes to pressing buttons. The researchers, led by Dr. Rebecca Monk, used a computer-based experiment to test this hypothesis and found significant evidence supporting their claim.
Research has isolated tyrosinase inhibitors from diverse chemical classes in both terrestrial and marine environments. Flavonoids, terpenes, and alkaloids have been found to exhibit potent tyrosinase inhibitory activities, with potential applications in treating skin disorders and neurodegeneration.
A PLOS ONE study found that inhibitory control affects physical problem-solving in pet dogs. The ability to 'wait-for-treat' was identified as a key factor in their problem-solving performance.
Transcranial direct current stimulation (tDCS) has been shown to reduce histamine-induced itching and shorten its duration in a new study. The results of this study are expected to contribute to the development of novel methods to inhibit itching.
Proton pump inhibitors are associated with rare but serious adverse effects, including heart attack, Clostridium difficile infection, and malabsorption of vitamin B12. Physicians should prescribe at the lowest dose possible and for the shortest length of time to minimize these risks.
A study published in the Journal of Clinical Endocrinology & Metabolism found that an enzyme called 11β-HSD1 is increased in muscles of older women, leading to reduced grip strength and insulin resistance. The researchers believe inhibiting this enzyme could hold the key to preventing or reversing muscle wasting associated with aging.
A new study published in Biological Psychiatry found that beta secretase inhibitors can impair synaptic plasticity and cognitive functions, highlighting the need for dose-dependent treatment. The researchers urge caution in dosing these inhibitors to balance safety and efficacy.
Researchers at Max Planck Institute of Psychiatry developed the first potent and highly selective inhibitor of FKBP51, called SAFit-ligand. This inhibitor enhances neuronal cell growth and improves stress-coping behavior in mice, providing a structural and functional basis for mechanistically novel antidepressant treatment.
A study by Lin Li et al. found that preconditioning crush reduces ventral motor neuron loss after nerve root avulsion. The authors propose a mechanism involving HSP27 induction, which attenuates cytotoxic effects of nitric oxide.
A study found that nearly three-quarters of PsA patients were on doses lower than recommended for infliximab, while a third of those on adalimumab had trough concentrations below the optimal level. Despite this, low dosing showed reasonable efficacy in both treatments.
Researchers have developed new tests to classify compounds' activity with great detail and speed, identifying safer replacements for BPA. The advance could offer a fast and cost-effective way to identify safe alternatives, as millions of tons of BPA and related compounds are produced each year.
Researchers found that preconditioning crush can increase the survival rate of motor neurons after spinal root avulsion. The study, published in Neural Regeneration Research, discovered that induction of heat shock protein 27 inhibits neuronal nitric oxide synthase, attenuating cytotoxic effects and preventing ventral motor neuron loss.
Researchers at Aarhus University have discovered a new way to treat high cholesterol by targeting the sortilin receptor system, which regulates PCSK9 protein levels. This breakthrough may lead to an alternative to statins for patients who cannot tolerate or benefit from them.
A University of Houston study found that anonymous online comments are more likely to be vulgar, racist, or hateful than those posted by non-anonymous users. Non-anonymous commenters were nearly three times as likely to post civil comments following news articles, with only 15% of anonymous commenters exhibiting civil behavior.
The study found that varespladib, an enzyme inhibitor, did not significantly reduce the risk of cardiovascular events in patients with recent acute coronary syndrome (ACS). Patients treated with varespladib had a higher risk of heart attack compared to those receiving placebo.
Astragaloside IV, a compound from traditional Chinese medicine, enhances sciatic nerve repair through anti-inflammatory and antioxidant effects. Upregulation of growth-associated protein-43 is associated with this process.
Researchers have developed substrate-selective COX-2 inhibitors that relieve anxiety behaviors in mice by activating natural endocannabinoids without gastrointestinal side effects. The findings suggest a new approach to treating mood and anxiety disorders, potentially paving the way for clinical trials and new treatments.
Researchers found short-term improvements in 68% of patients with FHD after low-frequency rTMS sessions, with reduced axial pen force and enhanced intracortical inhibition. However, clinical benefits were not sustained at longer follow-ups.
Research found short bouts of exercise enhance higher brain functions, including memory, concentration, planning, and decision-making, in all three age groups. Short exercises improved self-control, especially in children and teens, crucial for academic achievement and daily life.
Researchers found that blocking VEGF-A can decrease intraocular pressure but impair the ciliary body's function. This raises concerns about the long-term effects of aggressive anti-VEGF therapies on eye diseases like wet macular degeneration and diabetic macular edema.
A University of Innsbruck study found that interventions to promote women in competition increased their participation rates, particularly among highly qualified women. The experiment showed no negative impact on teamwork or efficiency.
Researchers found that women treated with aromatase inhibitors experience a wide range of side effects, including hot flashes, fatigue, and breast sensitivity. The study suggests that addressing these side effects is crucial for improving treatment adherence and patient outcomes.
The study reveals cell-type specificity of PI3K signaling in the mammalian brain, with PTEN tumor suppressor protein playing a crucial role. PDK1 deletion shows selective increase in AKT phosphorylation in glial cells, suggesting personalized cancer treatment approaches.
Darapladib's Lp-PLA2 inhibition prevents necrotic core expansion and plaque vulnerability in patients with coronary disease. Despite high standard care treatment, placebo-treated patients showed increased necrotic core volume, while daraplidib halted this increase.
Scientists at The Wistar Institute have developed a novel enzyme inhibitor that effectively blocks a key biochemical pathway in cancer development. By targeting the PI3K enzyme, the agent shows promise in treating melanoma by dampening overactive enzyme activity that leads to uncontrolled tumor growth.
Researchers have uncovered the molecular mechanism behind chloroform's action as a general anaesthetic, revealing its potential to design new anesthetics with reduced harm. Chloroform inhibits TRPC5 calcium ion channels, a key player in pain transmission and brain function.
The GABAA receptor's inhibition of learning has been reversed by its overexpression, revealing a complex relationship between neurotransmitters and cognitive processes. Fruit flies exhibit impaired learning at high temperatures but retain memory, suggesting that the receptor's absence may enhance neural plasticity.
Researchers at Rice University have engineered a modified form of the anti-cancer drug imatinib, known as WBZ_4, which targets specific cancer-causing proteins without affecting normal bodily functions. This new compound shows promise in treating gastrointestinal stromal tumors (GISTs) with reduced risk of heart toxicity.
Researchers found that carbon monoxide inhalation restores mitochondrial biogenesis in doxorubicin-treated mice, preventing cardiomyopathy. Overexpression of the protein HO-1 also reduced mitochondrial DNA damage and cell death in rat cardiac cells.
Researchers found that red wines, particularly Cabernet, Zinfandel, and Merlot, have anti-microbial properties that defend against food-borne pathogens. The study also showed that grape juice produces similar results, with reseveratrol being a key phytochemical responsible for the findings.
Researchers identified EP1 as a key factor in blood pressure regulation and found that inhibiting it can reduce hypertension. Targeting this receptor subtype may be a viable approach to treating high blood pressure.
Researchers found that housekeepers' perceived levels of exercise positively impacted their health, with significant weight loss and improved blood pressure. The study suggests the placebo effect plays a role in exercise's benefits.
A new report by Breast Cancer Action analyzes 612 women's responses to an online survey, finding nearly all reported side effects and 30% discontinued use due to intolerable side effects. The most common side effects included hot flashes, bone pain, and insomnia.
Two studies found increased cardiovascular and kidney risks associated with Cox-2 inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs). A meta-analysis of 114 randomized trials of COX-2 inhibitors revealed a class effect on renal events and arrhythmia events, but not for other COX-2 inhibitors.
A team of researchers has identified a potential alternative therapeutic option to COX-2 inhibitors by targeting microsomal prostaglandin E synthase-1 (mPGES-1). Inhibiting mPGES-1 suppresses PGE2 expression while augmenting PGI2 production, without affecting blood clotting or blood pressure.
Researchers identified a new class of anti-inflammatory drugs that may lessen cardiovascular risk by targeting microsomal prostaglandin E synthase (mPGES)-1. Unlike COX-2 inhibitors, mPGES-1 inhibitors do not increase the risk of heart attack and stroke while preserving some benefits.
Researchers found that blocking the nerve receptor EP1 significantly reduced brain damage in mice following stroke. The study suggests an alternative to COX inhibitors, which have lethal side effects.
Researchers found that older adults excel in visual processing tasks when the stimuli are large and high-contrast, whereas younger individuals struggle. This study provides evidence for changes in brain inhibition mechanisms as people age, shedding light on why older adults may perform better on certain visual tasks.
A study of 1,718 people found that COX-2 inhibitor rofecoxib was associated with a higher risk of heart attack compared to celecoxib and older non-selective non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs). In contrast, those who used NANSAIDs had a decreased risk for myocardial infarction.
Researchers found that melittin, a compound in bee venom, blocks the expression of inflammatory genes in synovial cells. This inhibition can lead to reduced tissue swelling and osteophyte formation, suggesting a potential treatment for RA patients.
MIF is a crucial intermediary in uncontrolled inflammation and impaired wound healing. In estrogen-deficient mice, MIF expression increased, leading to excessive inflammation and delayed healing. Therapeutics that inhibit MIF may accelerate wound healing.